1. Home
  2. DUO vs XXII Comparison

DUO vs XXII Comparison

Compare DUO & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUO

Fangdd Network Group Ltd.

HOLD

Current Price

$1.13

Market Cap

7.5M

Sector

Finance

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$3.89

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUO
XXII
Founded
2011
1998
Country
China
United States
Employees
N/A
N/A
Industry
Real Estate
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
3.3M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
DUO
XXII
Price
$1.13
$3.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.8K
34.7K
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,832,530.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.67
52 Week High
$5.34
$11.37

Technical Indicators

Market Signals
Indicator
DUO
XXII
Relative Strength Index (RSI) 46.66 42.88
Support Level $1.01 $3.61
Resistance Level $1.20 $6.86
Average True Range (ATR) 0.08 0.34
MACD 0.02 -0.17
Stochastic Oscillator 42.66 17.76

Price Performance

Historical Comparison
DUO
XXII

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: